FDA Approves New COVID-19 Vaccine, With Restrictions

Contact Your Elected Officials

The shot is the countryโ€™s only traditional protein-based vaccine for coronavirus.

Novavaxโ€™s new COVID-19 vaccine received long-awaited approval from the Food and Drug Administration (FDA) on Friday, but with specific restrictions.

The shot is the countryโ€™s only traditional protein-based vaccine for coronavirus, and previously, it only had emergency authorization from the FDA for use in those aged 12 and older.

Late on May 16, the FDA gave the company full approval to use the vaccine on adults 65 years or older. For anyone between the ages of 12 and 64, they must have at least one underlying health issue that would put them at risk if infected with COVID-19.

The mRNA COVID-19 vaccines developed by Novavax competitors Moderna and Pfizer are licensed without restrictions for anyone 12 years or older, and are also approved for useโ€”with some restrictionsโ€”in children as young as six months.

In June, advisers to the Centers for Disease Control and Prevention (CDC) are scheduled to deliberate on whether the agency should continue recommending yearly COVID-19 shots for everyone or just those who are at higher risk of complications from the virus.

The FDA decision on Novavax gives an early indicator of how the Trump administration may proceed ahead of that meeting.

Novavax chief executive John C. Jacobs celebrated the FDA approval.

โ€œMarket research and U.S. CDC statistics indicate that older individuals and those with underlying conditions are the populations most likely to seek out COVID-19 vaccination seasonally. This significant milestone demonstrates our commitment to these populations and is a significant step towards availability of our protein-based vaccine option,โ€ he said.

In the letter approving the vaccine on Friday, the FDA did not explain the restrictions, although the it said the vaccine has been shown to be safe and effective in a 30,000-person clinical trial.

Novavax said the FDA was asking the company to administer an additional post-approval trial, which is out of the norm.

The agency ordered multiple additional trials that would be completed in the proceeding years, with some analyzing potential heart complications. One that will evaluate the long-term potential for โ€œmyocarditis and pericarditisโ€ must be completed by Dec. 31, 2031, with the final report submitted on Sept. 30, 2032.

Byย Jacob Burg

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

ChatGPT Goes Biblical about End Times!

There are some truly outstanding internet content creators, or...

Epsteinโ€™s Niece Exposes the Illuminati!

There is a shocking interview by the podcaster Shaun Attwood, an English former ecstasy trafficker turned YouTube podcaster, speaker, activist, and author.

When Gynocrats Attack: Innocent Locker Room Talk Interrupted By Rabid Karen

The question posed: โ€œWho do you think has a...

Obamaโ€™s Treason is a Betrayal of American Democracy and Demands Real Accountability

Few scandals have cast a longer shadow than the 2016 Russia investigationโ€”the manufactured crisis by President Obama designed to cripple Trump's presidency.

Chronic Grievous Insufficiency

A president's physical vigor, stamina, and mental acuity are essential to his ability to fulfill the duties of office and those qualities should matter with no regard to party affiliation.

COVID-19 Pandemic Accelerated Brain Aging Even in People Who Didnโ€™t Get Virus: Study

Brain aging appears to have accelerated by months during COVID-19 pandemic, even in people who did not get sick from the virus, according to study.

US Witnessing โ€˜CapEx Comebackโ€™ as Investment Wave Hits Economy: Treasury

The U.S. economy is experiencing a โ€œCapEx Comebackโ€ this year as private-sector investment soars, the Treasury Department said.

New Study: COVID-19 Vaccinations Prevented 2.5 Million Deaths Globally, Mostly Among the Elderly

New global modeling study estimates that COVID-19 vaccinations prevented about 2.5 million deaths worldwide between December 2020 and late 2024.

Success of โ€˜What Ifโ€™ Flipped the Script for Both Creator Dallas Jenkins and Star Kevin Sorbo

For the first time, watch this never-seen-before behind-the-scenes footage, โ€œDirectorโ€™s Diaries,โ€ behind making of the faith-filled classic โ€œWhat If...โ€

Ex-DOJ Officials File Lawsuit Against Bondi Over Terminations

Former DOJ officials filed lawsuit against AG Bondi and the fed. govt, saying they were terminated for work on cases related to Jan. 6 Capitol breach.

Odds of U.S.-EU Trade Deal Are 50โ€“50 Ahead of Tariff Deadline: Trump

President Donald Trump said thereโ€™s a 50โ€“50 chance that the United States will finalize a trade deal with the European Union before an Aug. 1 deadline.

Trump Pulls Habbaโ€™s Nomination for New Jerseyโ€™s Top Prosecutor, Making Her Acting US Attorney

President Trump withdrew his nomination of Alina Habba to serve as NJโ€™s top federal prosecutor, making her Acting US Attorney.

Trump Says He Wants Muskโ€™s Companies to โ€˜Thrive Like Never Beforeโ€™

On Thursday, President Trump said, โ€œI want Elon, and all businesses within our Country, to THRIVE, in fact, THRIVE like never before!โ€
spot_img

Related Articles